Non-alcoholic fatty liver disease (NAFLD) has become an epidemic, much like other non-
communicable diseases (NCDs), such as cancer, obesity, diabetes, and cardiovascular …

Adipose tissue develops lipids, aberrant adipokines, chemokines, and pro-inflammatory
cytokines as a consequence of the low-grade systemic inflammation that characterizes …

Non-alcoholic fatty liver disease (NAFLD) is an important public health problem with growing
numbers of NAFLD patients worldwide. Pathological conditions are different in each stage of …

Abstract Background and Aims Non-alcoholic fatty liver disease (NAFLD) has become a
significant cause of chronic liver disease in developed countries, as a result of the worldwide …

Disease-modifying drugs have transformed the treatment options for many systemic
autoimmune diseases. However, an evolving understanding of disease mechanisms, which …

The liver plays a crucial role in lipid metabolism and metabolic homeostasis. Non-Alcoholic
Fatty Liver Disease (NAFLD) is the most common chronic liver disease worldwide and …

Metabolism of carbohydrates and lipids and protein degradation occurs in the liver and
contributes to the body's homeostasis by secreting a variety of mediators. Any imbalance in …

Fibrotic diseases affect multiple organs and are associated with morbidity and mortality. To
examine organ-specific and shared biologic mechanisms that underlie fibrosis in different …

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder.
Defects in function/expression of genes/proteins are critical in initiation/progression of …

Abstract Objective The GH and IGF-1 axis is a candidate disease-modifying target in
nonalcoholic fatty liver disease (NAFLD) given its lipolytic, anti-inflammatory and anti-fibrotic …